Deep01 is the first AI company in Asia to obtain
US and Taiwan FDA clearances
Our mission is to improve medical quality by providing AI solutions
Midline shift detection and measurement
ICH detection, localization, and notification
AI-powered emergency stroke and head trauma network
The team members of Deep01 are from Harvard University, Oxford University, Carnegie Mellon University, National Taiwan University, and Tsinghua University with profound international work experience and from senior physicians in the US and Taiwan.
David Chou, the founder and CEO of Deep01, graduated from Carnegie Mellon University Computer Science and was a Harvard University research fellow. https://www.linkedin.com/in/deep01/
US Plug & Play is an investor in Deep01.
Deep01 won the 2nd place out of 900+ teams in a Beijing, China Startup Contest. Deep01 also won the 1st place in the semi-final competition in Taiwan.
Deep01 was top-picked as the TIEC team for Silicon Valley Plan and TechCrunch SF.
Deep01 won the 2nd place in the Dark Horse Contest, the most famous startup contest in China. Deep01 also won the 1st place in the semi-final in Taiwan.
Taiwan Capital TEN (Tsing Hua Entrepreneur Network) is an investor in Deep01.
Deep01 was top-picked as a Harvard MGH fellow with a full scholarship by the Leap Program.
Deep01 was the first AI startup in the Asia-Pacific region to obtain FDA clearance.
Deep01 won the Taiwan Innovation award.
Deep01 was awarded as 2020 Taiwan Top 10 Startups by the Minister of Science and Technology.